Condition: Epilepsy · Sponsor: Neuronostics Ltd
Neuronostics plan a prospective multisite trial to determine the clinical utility of BioEP in the context of diagnostic decision making. Neuronostics will use findings from the trial to improve user experience of the Neuronostics platform (the tool which clinicians use to obtain a BioEP score from EEG and the aligned report). The data coming from the trial will also enable Neuronostics to iterate the BioEP algorithms and so improve future performance.
This description comes directly from the study's public registry record.
Wessel Woldman · +44 (0)117 457 2292 · w.woldman@neuronostics.com
Verity Fuller · v.fuller@neuronostics.com
Always discuss trial participation with your own doctor first.
| Royal Cornwall Hospitals Trust | Truro, United Kingdom | Recruiting |
| The Royal Wolverhampton NHS Trust | Wolverhampton, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06097195